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Abstract
Background: Microarray technology allows the analysis of genomic aberrations at an ever increasing resolution,
making functional interpretation of these vast amounts of data the main bottleneck in routine implementation of
high resolution array platforms, and emphasising the need for a centralised and easy to use CNV data
management and interpretation system.
Results: We present CNV-WebStore, an online platform to streamline the processing and downstream
interpretation of microarray data in a clinical context, tailored towards but not limited to the Illumina BeadArray
platform. Provided analysis tools include CNV analsyis, parent of origin and uniparental disomy detection.
Interpretation tools include data visualisation, gene prioritisation, automated PubMed searching, linking data to
several genome browsers and annotation of CNVs based on several public databases. Finally a module is provided
for uniform reporting of results.
Conclusion: CNV-WebStore is able to present copy number data in an intuitive way to both lab technicians and
clinicians, making it a useful tool in daily clinical practice.
Background
Up to 12% of the humane genome is present in a variable
number of copies, referred to as copy number variation
(CNV) [1-3]. A small subset of specific CNVs is shown to
associate with a wide spectrum of diseases [4-9].
Before the development of array-based comparative
genomic hybridisation, visual inspection of karyotypes
under the microscope limited the detection of chromo-
somal aberrations to events larger than 5 to 10 Mb. A
major breakthrough was achieved with the generation of
BAC-arrays, initially consisting of about 2000 large-
insert clones spotted on a glass back plate [10]. With
the capacity to screen a whole genome at once at a
practical resolution of about 1.4 Mb, this type of array
launched the CNV-analysis field in routine diagnostics.
More recently, the resolution of BAC-arrays was
improved using over 20000 tiling probes [2]. At present,
BAC-arrays are gradually replaced by higher resolution
platforms such as oligonucleotide- and SNP-arrays
[11,12]. The major advantage of SNP-arrays over
oligonucleotide- and BAC-arrays, is that they provide
g e n o t y p ei n f o r m a t i o ni na d d i t i o nt oi n t e n s i t yr a t i o s .
Combining both information layers gives these platforms
the potential to detect CNVs at a significantly higher
resolution than the first generation platforms [13,14].
This increased resolution, in combination with the
wide variety of data analysis methods, causes a shift of
focus from data generation to data interpretation. To
interpret these calls in a clinical context several aspects
typically need to be taken into account [8] and several
tools are available to aid in this process [15-17]. While
many tools exist for either data analysis or presentation
and interpretation, few exist that efficiently combine
both [18-23]. Here, we present CNV-WebStore, a web-
b a s e dp l a t f o r mt h a tc o u p l e sd a t aa n a l y s i sw i t hd a t a
storage, visualisation, several downstream analysis
methods and reporting tools, to serve as a complete
data to report pipeline (figure 1).
The presented platform incorporates a majority vote
based analysis pipeline specific for Illumina BeadArray
data, capable to detect CNVs with a lower limit of 3
consecutive probes, mosaicism and uniparental disomy.
Though analysis of data generated on other platforms is
not supported, CNV sets from any platform can be
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integration of multiple experimental techniques in a sin-
gle interpretation pipeline.
Platform Implementation
Interface architecture
CNV-WebStore is hosted on an 8 core, 64bit Suse Linux
Enterprise Enterprise Server with 16 Gb RAM, running
Apache v2.2.0, PHP v5.2.3 and MySQL v5.1.39. All
interface components are composed of PHP and Java-
Script, with support for most major browsers. Annota-
tion data is automatically updated on a weekly basis
using scheduled Perl scripts. Default data analysis times
range from 2 minutes per sample for 300 K arrays, to
10 minutes for 1 M arrays.
Data analysis packages
All analysis methods were run in their native program-
ming language in a 64bit Linux environment, and com-
bined by a wrapper script written in Perl v5.8.8 with
multithreading support.
QuantiSNP v1.1 was installed and used confirming to
the Academic licence. Parameters were set mainly at
default values, namely 10 Expectation-Maximisation
steps, 2 M as characteristic length for CNVs and a max-
imal copy number of 4. Additionally, correction for local
GC content was applied. Minimal Log Bayes Factor was
set at 8.5 based on experimental experience [24].
PennCNV rev081119 was installed and run with the
generic markov model and population frequency of
B-alleles, since no chip-specific files were available. No
family information was used and minimal confidence
was set to 10 based on experimental experience [25].
VanillaICE v1.4.0 was installed under R v2.9.0 and
configured according to the authors suggestions for ana-
lysing Illumina data. Expected intensity ratios were
adapted following technical guidelines from Illumina
and emission probability calculations were set to cope
with non-polymorphic probes. Samples were analysed
individually, so we chose a robust in sample estimate of
intensity variability as proposed by the author [26]. A
complete overview of the used settings is available as
additional file 1.
BAFsegmentation v1.1.0 was installed under R v2.9.0.
Program parameters were set to 0.97 as ‘informative_-
treshold’,0 . 8a s‘triplet_treshold’,0 . 5 6a s‘ai_treshold’
and 4 as ‘ai_size’ [27].
SNPtrio [28] calculations were implemented as
described by the authors using Perl.
Results
Data analysis approach
To make a correct functional interpretation of CNV data,
it is necessary to be able to start from a reliable set of
candidate regions. We therefore implemented an analysis
pipeline for the Illumina BeadArray platform, aimed at
detecting rare, small scale CNVs. Since many methods
have already been published and mutually compared for
the analysis of SNP-array data, we decided to use existing
methods, instead of creating yet another [24-26,29-31].
The pipeline uses the widely used approach of majority
vote based calling, as previously described for the Affy-
metrix platform [32], to generate a restrictive set of
results, with a higher sensitivity and specificity (figure 2).
Specificity is increased by discarding CNVs called by only
1 of the 3 methods, usually representing method specific
artefacts. An increase in sensitivity over each single
method is reached by adding regions that were called by
2 methods, but not by the third. CNV delineation is done
with a conservative overlap, retaining only regions seen
by more than one method.
Previous studies comparing multiple computational
methods for microarray analysis showed that Hidden
Markov Model (HMM) based methods perform best
in detecting rare and small CNVs. These methods
explicitly combine intensity and genotype data, take the
Figure 1 Platform structure overview of CNV-WebStore.
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underlying assumption of general diploidy, although
they have a significantly larger computational footprint
than classic aCGH segmentation methods [13,26,33]. In
addition, results are sample size independent, in contrast
to some recent methods that use a joint calling algo-
rithm over multiple samples [34]. Although joint-calling
can be a very powerful tool in GWA projects for the
detection of recurrently variable regions, population
dependent CNV calls are unacceptable in a clinical con-
text where all results have to be reproducible under any
circumstance. We chose QuantiSNP and PennCNV
because they are the two most widely accepted and used
HMM methods for Illumina data analysis today, and
VanillaICE for its claimed high sensitivity to deletions,
which are responsible for approximately 70% of patho-
genic events described so far [8].
Besides general copy-number analysis, the data are
screened for indications of mosaicism based on quality
control parameters, as described below. BAFsegmenta-
tion is used with default settings to detect regions of
aberrant B-allele frequency, and to estimate the propor-
tion of cells containing the allelic imbalance [27].
Finally, uniparental disomy detection is implemented
using the method described by Ting et al. [28]. Based on
informative combinations of mendelian inconsistencies,
uniparental heterodisomy, isodisomy and non-paternity
can be deduced from the provided genotype data.
Performance estimation
To estimate performance of the proposed majority vot-
ing, its stringency and sensitivity were compared against
the separate methods using a reference dataset gener-
ated by Pinto et al. using an approach similar to ours
[32], and a dataset of 192 HapMap samples generated
by Illumina on the HumanCNV370-Quad BeadChip,
from which 181 samples were also present in the former
study. None of the separate methods performed signifi-
cantly better in picking up the previously published
C N Vr e g i o n sf r o mt h eI l l u m i n ad a t a( T a b l e1 ) .S i m i l a r
results were obtained using a set of CNVs seen in a
study by McCarroll et al on the Affymetrix 6.0 array [3]
(data not shown).
The slight sacrifice in sensitivity towards duplications,
caused by incorporation of VanillaICE in the majority
vote, can be countered by taking advantage of the
observed high power of PennCNV in detecting duplica-
tion events. To do so, an option for asymmetric voting,
where PennCNV duplication calls do not need to be
confirmed by a second method, is available.
When applied to the full panel of 192 high quality
HapMap samples, we retrieved a set of 8779 aberrations.
This corresponds to a mean of 45 aberrations per sam-
ple and to 4% of the genome present in a variable num-
ber of copies over all the samples. This high number of
CNVs per sample seems out of range with previous stu-
dies. When classified by size or coverage (figure 3), it is
clear that most of the called CNVs are found in the
category of 3-6 consecutive probes. Thus, it appears that
the increase in resolution results in an increase in the
number of additional small CNVs detected. Indeed,
using an artificial resolution of 100 Kb, corresponding
to 15 consecutive probes, we detected 8 CNVs per sam-
ple, in range with an average of 6 CNVs per sample
detected on a 85 K oligonucleotide platform with a
practical resolution of 100 Kb [4].
Quality Control
Quality control parameters are stored during analysis
and user feedback is given if they exceed preset values.
High quality samples are considered to have a call rate
of >99.4%, LogR standard Deviation < 0.2, B-allele
Figure 2 Analysis pipeline implemented in CNV-WebStore for
Illumina BeadArray data.
Table 1 Proportion of CNVs called by Pinto et al.
detected by the different methods used
Pinto et al.
Deletions
(n = 378)
Duplications
(n = 130)
Overall
(n = 508)
Algorithm % P-Val % P-Val % P-Val
2/3 Vote 81.5 69.6 74.4
QuantiSNP 79.0 0.19 66.0 0.26 71.3 0.13
PennCNV 80.0 0.3 75.2 0.16 77.2 0.15
VanillaICE 83.0 0.31 55.1 0.0073 66.3 0.0023
Results are averaged over 181 HapMap samples. P-values are calculated using
a one-tailed z-test for difference between proportions, comparing the majority
vote against each separate method.
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< 0.03. In case of genomic waving, an event where the
intensity data shows typical fluctuation across the chro-
mosomes, normalisation is performed during CNV ana-
l y s i s[ 3 5 ] .Q C - v a l u e sa r et a k e nf r o mP e n n C N Vo u t p u t .
Chromosome specific B-Allele standard deviation, cal-
culated by QuantiSNP, is screened for significant outliers,
as these might be an indication of mosaicism. When
mosaicism is suspected, the user is informed of possible
mosaicism and BAFsegmentation is started [27].
Other Platform Data
To import generic CNV reports, custom parsers can be
generated for any tab-separated file. Once imported into
the database, family relations and raw probe level data
can be added. When this raw data is available, inheri-
tance examination and parent of origin analysis can be
carried out as described below.
Sample Annotation
Default annotation of samples consists of quality control
data, used platform type, gender and the total number
of detected aberrations. Additionally, clinical data can be
added. Structured clinical information, conforming to
the London neurogenetics nomenclature [36], aids in
unambiguous comparison and grouping of samples
based on their phenotype.
CNV Annotation
Clinical interpretation of CNVs requires a comprehen-
sive cross-linking of available annotation data. Besides
experimental data such as aberration size, copy number
state, inheritance data and genome build, several addi-
tional annotations are automatically added (figure 4).
Affected RefSeq genes [37] are listed, with associations
to phenotypes extracted from OMIM [38]. Known dis-
ease related loci and published case reports are extracted
from the DECIPHER and ECARUCA databases [15,39].
Finally, information on flanking segmental duplications is
available, as these often flank recurrent microdeletion
and -duplication regions [40]. The Toronto Database of
Genomic Variants is a major collection of known benign
variants detected in control populations [1]. The database
comprises a total of almost 40 studies, from which a user
can select a subset used for automatic annotation. As a
second source of healthy controls, all HapMap samples
analysed by Illumina to create the reference cluster files,
passing our quality control requirements, were analysed
by the described pipeline for all supported chip types and
presented to the user as a chip-specific control set [11].
Figure 3 Overview of 8779 copy number variations detected in 192 HapMap Samples. On the left axis, the number of deletions per sample
are shown as light bars, duplications as dark bars. On the right axis the percentage of aberrations in the bin, containing genes is shown. A)
Classified by coverage. B) Classified by aberration size.
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further annotated with inheritance information, parent
of origin information for de novo events and uniparental
iso- or heterodisomy prediction [28].
Data management and protection
All data are stored in a relational database which is backed
up on a daily basis. Access to specific data using CNV-
WebStore is regulated by user-level permissions. Users
are allowed to manage and share their own data with
different users or user groups, with varying privileges, ran-
ging from read-only access, over the privilege to only edit
clinical or CNV annotations, to the right to further share
data with more users. In order to guarantee data integrity,
all changes in annotation are kept by a logging system.
Sample anonymity is ensured as there is no storage of per-
sonal information, such as names or birth dates. Sample
identification relies on arbitrary identification codes speci-
fied by the user. A typical example would be a numeric
identifier linking to the DNA sample that was analysed.
Data Representation
Centralised storage of all data allows flexible presenta-
tion and searching approaches. By default CNV-
WebStore presents data in a compact graphical browser
(see figure 4). CNV regions are denoted by bars using a
color code representing copy number and clinical signif-
icance. Results from multiple experiments can be
combined in a single overview or can be visualised sepa-
rately. The graphical representation allows intuitive cor-
relation of results with previous results, gene content,
known pathogenic regions and benign variants. It
further provides access to inheritance information,
probe level data for visual examination, quality control
results, general sample information and several public
resources for extensive investigation of annotation data
[38,41,42] (see figure 5). Individual users can select the
resources they consider relevant to be included, or add
new resources available to all users.
Alternatively, data for a single sample can also be pre-
sented in a tabular format. Here, clinical data is bundled
with experimental data, CNV annotation, occurrence
statistics and reporting tools. Additional annotation
tools present from here are a direct PubMed querying
tool to intersect the clinical data with gene content, and
a CNV prioritization option based on the Endeavour
program [19].
Reporting
The reporting module of CNV-WebStore provides uni-
form and comprehensive summaries of annotated data.
Users have the option to include clinical and experimental
Figure 4 Graphical representation of CNV-annotation by CNV-WebStore. General color codes are green for duplication and purple for
deletion events. OMIM information for genes is indicated by blue or red (MORBID) color.
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all or a filtered subset of detected aberrations, gene con-
tent and annotation history.
Exporting
To analyse data using other tools, results can be
exported as Tab separated files, BED files compatible
with UCSC and Ensembl genome browsers, or XML
files compatible with Illumina Genome Viewer.
Discussion
SNP-based microarray platforms are used more and
more in daily diagnostics, providing the potential to ana-
l y s eap a t i e n t ’s genome at high resolution on both
genotype and copy number level. As for many of today’s
technologies, the amount of produced data is vast and
interpretation becomes a cumbersome task.
To overcome this, and to help sieve through the many
generated CNV calls, we developed CNV-WebStore, a
centralised analysis and interpretation platform, able to
go from raw data to reports from a single interface. It
implements a majority vote analysis pipeline combining
three HMM based methods, each using slightly different
underlying models, with a net effect of filtering out
model specific artefacts. A similar approach has been
successfully applied on Affymetrix 500 K SNP array
d a t a ,t oo b t a i nas t r i n g e n tC N Vs e tc o n s i s t i n go ft h e
most reliable calls [32].
From our results, two observations were made under-
scoring that obtaining the correct functional correlation
between genotype and phenotype is the major hurdle in
routine microarray usage. First, about 30% of the smal-
lest detectable CNVs on the used platform disrupt 1 or
more known coding sequences, often affecting exonic
sequence. Second, CNVs affecting only intronic
sequence might still contribute to specific phenotypes,
as intronic sequences often harbour non-coding tran-
scripts, which are currently emerging as key regulators
in many diseases [44-46]. Furthermore, we expect that
with the rising probe density of current and future
microarray platforms, and with new techniques such as
next generation sequencing based CNV calling, the
amount of small variants detected will keep increasing,
stressing the importance of a straightforward interpreta-
tion platform such as CNV-WebStore.
Interpretation tools made available to the user are
presented in a unified way, offering maximal informa-
tion with minimal effort. CNV-WebStore offers both
molecular data, automatic CNV annotation and clinical
information, in the context of public reference data or
previous experimental results. The option to correlate
clinical information with extended annotation data from
a single view is a feature seen in some public platforms
such as DECIPHER, but lacking in other platforms for
routine usage [15,21-23]. Furthermore, the option to
analyse data from the platform itself, without the need
to use a command line interface is a major benefit of
our platform over existing, similar interpretation solu-
tions [15,21]. Finally, the capability to infer parent of
origin and uniparental disomy from stored genotyping
data is a unique feature of CNV-WebStore with clear
impact on functional interpretation of imprinting related
disorders [47]. A drawback might be that HMM based
methods assume integer copy number values, limiting
the possible application of the presented analysis pipe-
line in cancer research [27]. On the other hand, as
incorporation of post-analysis results is supported for
any type of data, including better suited segmentation
Figure 5 Context Information presentation. A single tooltip
allows access to parental data (on top), clinical information and
public resources (middle) and visual examination plots (bottom).
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added value for interpretation of these data.
By integrating both data analysis, storage and presen-
tation into a single platform, the problem of computa-
tional resources might impose a practical limit on
usability. To address this, a system monitor is imple-
mented in the analysis pipeline that distributes the sys-
tem load to those processors that are spare in the
system. Cloud computing, as illustrated recently for the
Reciprocal Smallest Distance Algorithm, was also con-
sidered [48]. As a hosting server with 8 cores and 2 Gb
RAM per core is able to analyse samples with 1 M mar-
kers in less than 10 minutes, the actual limit lies in data
storage and not in computational power, which is nowa-
days easily managed, without the large financial over-
head of renting cloud-based storage.
Conclusions
By combining microarray data analysis with centralised
storage, a comprehensive start point was created for data
interpretation, the major task in current diagnostic usage
of microarray data. The ability to compare results against
clinical information, previously analysed samples, known
variant regions and gene content allows a sensitive selec-
tion of CNVs to obtain the most relevant results for
further research. Extensive logging enables the tracking
of changes to every sample or region, making CNV-Web-
Store a useful tool in a collaborative setup.
In conclusion, we have developed a web based plat-
form providing an intuitive pipeline to go with minimal
effort from raw data to functional interpretation and
reporting of results. Because both lab technicians and
clinical staff can annotate the data from their own
expertise, the most relevant regions will most likely
come forward. This makes CNV-WebStore a valuable
tool in daily clinical practice, where modern techniques
often produce overwhelming amounts of data.
Availability and requirements
￿ Project Name: CNV-WebStore
￿ Project Home Page: http://sourceforge.net/projects/
cnv-webstore
￿ WebService Address: http://medgen.ua.ac.be/cnv
￿ Operating Systems: UNIX-like 64bit OS
￿ Programming Language: Perl/PHP/R/MySQL
￿ Other Requirements: LAMP server
￿ License: GNU GPL, free for academic usage
Additional material
Additional file 1: VanillaICE code and settings. VanillaICE settings
were adapted to optimise performance on Illumina BeadChip data. This
files contains the resulting R-code that can be used with version 1.4.0.
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